a
a
Weather:
No weather information available
HomeHealthArgent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management

Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management

Advanced wound care market projected to exceed $15 billion globally by 2030 PERTH, Australia , Feb. 12, 2025 /PRNewswire/ — Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds…

No comments

Sorry, the comment form is closed at this time.

Translate »